Jill Piens

497 total citations
7 papers, 395 citations indexed

About

Jill Piens is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Jill Piens has authored 7 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Otorhinolaryngology. Recurrent topics in Jill Piens's work include Cancer Treatment and Pharmacology (3 papers), Oral Health Pathology and Treatment (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Jill Piens is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Oral Health Pathology and Treatment (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). Jill Piens collaborates with scholars based in United States. Jill Piens's co-authors include Alex A. Adjei, Joel M. Reid, David Mitchell, Mark B. Meyer, Lorelei J. Hanson, Mary Varterasian, Laura M. Bruzek, Pamela DeLuca, Keri Van Becelaere and Román Herrera and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Supportive Care in Cancer.

In The Last Decade

Jill Piens

7 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jill Piens United States	4	296	214	81	60	36	7	395
Josh Ballard United States	3	349 1.2×	184 0.9×	81 1.0×	70 1.2×	40 1.1×	3	468
Katie Kane United Kingdom	6	363 1.2×	256 1.2×	77 1.0×	101 1.7×	33 0.9×	9	531
Joe Lyssikatos United States	6	380 1.3×	207 1.0×	87 1.1×	80 1.3×	54 1.5×	8	502
Calvo Medina United States	6	239 0.8×	164 0.8×	44 0.5×	33 0.6×	24 0.7×	7	339
Heike Seifert United Kingdom	8	286 1.0×	199 0.9×	52 0.6×	62 1.0×	14 0.4×	13	381
Christina Mateus France	6	287 1.0×	222 1.0×	41 0.5×	44 0.7×	17 0.5×	11	524
Jason R. Todd Australia	7	245 0.8×	151 0.7×	52 0.6×	33 0.6×	18 0.5×	8	310
Liv Johannessen United States	8	241 0.8×	152 0.7×	30 0.4×	57 0.9×	42 1.2×	19	374
Flora Luo United States	7	205 0.7×	100 0.5×	62 0.8×	103 1.7×	20 0.6×	9	390
Jennifer Gauvin United States	9	352 1.2×	141 0.7×	128 1.6×	99 1.6×	32 0.9×	11	529

Countries citing papers authored by Jill Piens

Since Specialization

Citations

This map shows the geographic impact of Jill Piens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Piens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Piens more than expected).

Fields of papers citing papers by Jill Piens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Piens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Piens. The network helps show where Jill Piens may publish in the future.

Co-authorship network of co-authors of Jill Piens

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Piens. A scholar is included among the top collaborators of Jill Piens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Piens. Jill Piens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Cathcart-Rake, Elizabeth, David Zahrieh, Susan E. Young, et al.. (2023). A five arm natural history study of nasal vestibulitis. Cancer Medicine. 12(8). 9650–9654. 1 indexed citations

Cathcart-Rake, Elizabeth, David Zahrieh, Susan E. Young, et al.. (2021). Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) study. Supportive Care in Cancer. 29(11). 6253–6258. 1 indexed citations

Šikić, Branimir I., Heather A. Wakelee, Alex A. Adjei, et al.. (2006). 342 POSTER A phase I dose-escalation and pharmacokinetic (PK) study of XL647, a novel spectrum selective kinase inhibitor, administered orally to patients with advanced solid malignancies (ASM). European Journal of Cancer Supplements. 4(12). 106–107. 2 indexed citations

Wakelee, Heather A., Alex A. Adjei, Joanne Halsey, et al.. (2006). A phase I dose-escalation and pharmacokinetic (PK) study of a novel spectrum selective kinase inhibitor, XL647, in patients with advanced solid malignancies (ASM). Journal of Clinical Oncology. 24(18_suppl). 3044–3044. 20 indexed citations

Bible, Keith C., Yean Kee Lee, Joel M. Reid, et al.. (2005). Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in Patients with Advanced Malignancies with the Assessment of Pharmacokinetic and Pharmacodynamic End Points. Clinical Cancer Research. 11(16). 5935–5941. 50 indexed citations

LoRusso, Patricia, Alex A. Adjei, Mary Varterasian, et al.. (2005). Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies. Journal of Clinical Oncology. 23(23). 5281–5293. 316 indexed citations

Wakelee, Heather A., Alex A. Adjei, Harold Keer, et al.. (2005). A phase I dose-escalation and pharmacokinetic (PK) study of a novel multiple-targeted receptor tyrosine kinase (RTK) inhibitor, XL647, in patients with advanced solid malignancies. Journal of Clinical Oncology. 23(16_suppl). 3142–3142. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact